Prestige Wealth Management Group LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1772715
FLEMINGTON, NJ
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$48,676
+$1,593 QoQ
Shares Held
63
+3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prestige Wealth Management Group LLC holds $563,805 across 26 Biotechnology names. REGN ranks #3 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
847 | $378,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
226 | $74,776 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
63 | $48,676 | |
| 4 | INCY |
Incyte Corp
|
132 | $12,423 | |
| 5 | MRNA |
Moderna, Inc.
|
137 | $6,959 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
107 | $6,708 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
200 | $6,512 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
250 | $5,890 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,676 | 63 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $47,083 | 61 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $45,543 | 81 | Shares | Other | 2026-02-20 | |
| 2025-06-30 | $45,675 | 87 | Shares | Other | 2026-02-20 | |
| 2025-03-31 | $57,080 | 90 | Shares | Other | 2026-02-20 | |
| 2024-12-31 | $71,945 | 101 | Shares | Other | 2026-02-20 | |
| 2024-09-30 | $86,201 | 82 | Shares | Other | 2026-02-20 | |
| 2024-06-30 | $107,204 | 102 | Shares | Other | 2026-02-20 | |
| 2024-03-31 | $145,335 | 151 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $146,673 | 167 | Shares | Other | 2024-04-26 | |
| 2023-09-30 | $141,548 | 172 | Shares | Sole | 2024-04-26 | |
| 2023-06-30 | $121,432 | 169 | Shares | Sole | 2024-04-26 | |
| 2023-03-31 | $378,789 | 461 | Shares | Other | 2024-04-26 | |
| 2022-12-31 | $121,210 | 168 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $123,306 | 179 | Shares | Other | 2022-11-01 | |
| 2022-06-30 | $106,994 | 181 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $122,223 | 175 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $295,550 | 468 | Shares | Other | 2022-02-15 | |
| 2021-09-30 | $211,812 | 350 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $73,168 | 131 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $63,873 | 135 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $44,928 | 93 | Shares | Other | 2021-02-17 | |
| 2020-09-30 | $101,320 | 181 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $92,923 | 149 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $24,414 | 50 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||